01 March 2011: Clinical Research
Confirmation of HIV-like sequences in respiratory tract bacteria of Cambodian and Kenyan HIV-positive pediatric patients
Vladimir Zajac ADEF , Lenka Matelova ABC , Anna Liskova B , Michal Mego ABC , Vladimir Holec AEF , Zuzana Adamcikova ABC , Viola Stevurkova AEF , Andrea Shahum BG , Vladimir Krcmery BG
DOI: 10.12659/MSM.881449
Med Sci Monit 2011; 17(3): CR154-158
Background
It has recently been found that both acute human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are accompanied by a dramatic and selective loss of memory CD4+ T cells, predominantly from the mucosal surfaces [1].
Gut-associated lymphatic tissue (GALT), the largest component of the lymphoid organ system, is a principal site of both virus production and depletion of primarily lamina propria memory CD4+ T cells. CD4-expressing T cells that previously encountered antigens and microbes are homed to the lamina propria of GALT [2]. The scale of this CD4+ T-cell depletion has adverse effects on the immune system of the host, emphasizing the significance of developing countermeasures to SIV that are effective before infection of GALT. The SIV directly killed a massive number of immune cells in the gut within days of infection. The gut-associated lymphoid tissue (GALT) is an important early site for HIV replication and severe CD4+ T cell depletion [3]. Viral suppression and immune restoration exists in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection [3]. In individuals treated with highly active anti-retroviral therapy (HAART), the plasma HIV RNA is reduced to below the level of detection, but there is strong evidence of continuing viral replication after suppression of plasma viremia. It is apparent that a viral reservoir persists in virtually all infected individuals receiving HAART [4,5]. As shown previously, HIV-1 was also detected in bowel crypt cells and the lamina propria in HIV-positive patients [6]. Since these cells are in close contact with intestinal bacteria, it may be possible that bowel bacteria are involved in the pathogenesis of the disease. These findings, confirming that the gut and other mucosal tissue, rather than blood, is the major site of HIV infection and CD4+T cell loss, suggest the possibility that bacteria might serve as a viral reservoir as well.
Based on our previous results concerning detection of HIV-1 sequences in gastrointestinal tracts of HIV-positive patients [7–9], we analysed bacteria and yeasts isolated from the respiratory tract (nose, pharyngeal swabs) of Cambodian and Kenyan HIV-positive children for presence of HIV-like sequences. The study protocol was reviewed and approved by the
Material and Methods
DNA ISOLATION AND PCR AMPLIFICATION:
Bacteria and yeasts from the respiratory tract (nose, pharyngeal swabs) were collected from 39 Cambodian and 28 Kenyan HIV-positive children.
Collected samples were directly transported from Cambodia and Kenya to the Cancer Research Institute in Bratislava and incubated overnight in LB medium at 37°C for amplification. Bacterial chromosomal DNA was prepared by standard protocol [10,11] and by Qiagen kit (Qiagen). Plasmid DNA was purified by an alkaline lysis procedure (Table 1).
To avoid false positive results, 3 PCR reactions were performed as arbitrary controls in every set of reactions. The PCR products, used for sequencing and for HIV-specific probe, were purified through LMP agarose and by QIAquick PCR purification kit (Qiagen). Plasmid pBH10 (genebank accession number M15654) was used as a reference source of HIV DNA and lymphocytes’ DNA of HIV/AIDS patient 30 was used as a template for PCR products.
DOT-BLOT HYBRIDIZATION:
For dot-blotting, bacteria and yeasts isolated from patients were amplified overnight in LB medium, and chromosomal DNA was prepared. DNA (0.25 μg/sample) of each patient was transferred to Hybond N+ membrane, lysed and prehybridized. For probe, the 3 aforementioned purified PCR products were synthesized on DNA template: a) HIV/AIDS patient 30; b) plasmid pBH10. 32P-labelled probe was obtained by Ready-To-Go DNA Labelling Kit (Amersham Bioscience, England). Hybridization was performed for 16 hours in standard hybridization buffer at 42°C or in Rapid-hyb buffer (Amersham Bioscience) at 60°C, and washing was carried out as described previously [9]. To exclude potential contamination, 8 DNA samples of healthy persons were analysed together with tested children.
SOUTHERN HYBRIDIZATION:
For colony blotting, bacterial suspension was diluted to the concentration of 10−10 or 10−9 on LB plates and grown colonies were blotted to the Hybond N+ membrane, lysed, washed and prehybridized. 32P-labeled probes were obtained using Ready-To-Go DNA Labeling kit (−dCTP) (Amersham Bioscience). The combined PCR probe was prepared as a mixture of all 3 aforementioned PCR products. Hybridization was performed for 16 hours in standard hybridization buffer at 42°C or in Rapid-hyb buffer (Amersham Bioscience) at 60°C. Subsequently, membranes were washed at final temperature 60°C, resp. 65°C.
DNA SEQUENCING:
The PCR products determined by primers 68, 69 synthesized on the template of bacterial DNA were directly sequenced on the ABI 373 DNA Sequencer and ABI PRISM 310 Genetic Analyzer (Applied Biosystem). The sequencing reaction was performed using fluorescent dyes of the ABI Prism Big Dye Terminator sequencing kit (Applied Biosystems) and afterwards extension products were purified by Auto-Seq G-50 columns (Amersham Biosciences).
Results
The bacteria and yeast isolates from the respiratory tract of Cambodian and Kenyan HIV-positive children were
The results of colony (data not shown) and dot-blot hybridization were highly compatible. The differences in hybridization using probes of PCR products synthesized on 2 different templates – pBH10 and DNA of patient 30 – were not significant.
The 142 bp amplicon limited by primers 68; 69 produced using template DNA from both bacteria and lymphocytes of Kenyan (9 Ke, 22 Ke, 10’ Ke, 30 Ke, 5’ Ke, 16’ Ke, 29 Ke) and Cambodian children (15 Cm, 28 Cm, 33 Cm) was sequenced (Figure 3). Amplicons from these different sources were more than 90% identical with reference sequences (HIV/HXB2). Some differences were found in the first part of sequenced fragments. Largest differences were detected between the isolates as a group and the reference sequence in pBH10.
Discussion
Recent observations suggest that the main fight against the HIV disease process is performed in gut-associated lymphatic tissue closed to the gastrointestinal tract [1–3,11]. Our understanding about the restoration of the gut mucosal immune system during highly active antiretroviral therapy is very limited. A dramatic loss of CD4+T cells, predominantly from the mucosal surfaces, suggests the question of whether bacteria play some role in this process. Our previous detection of HIV-like sequences in gut bacteria of HIV/AIDS patients may confirm that bacteria are involved in this trial [7,12,13]. Accordingly, in the respiratory tract bacteria of HIV-positive children from Cambodia and Kenya, HIV-like sequences were detected in 41% and 29%, respectively, of samples.
On the basis of our previous detection of HIV-like sequences in bacteria isolated from the respiratory tract of AIDS patients [7], it is possible to conclude that bacteria bearing HIV-like sequences are localized not only in the intestinal tract of HIV/AIDS patients, but in other organs as well [12,13]. The transmission of these organisms and their role in AIDS pathogenesis is not clear. Some bacteria probably may serve as a reservoir of HIV-like sequences in the form of “virus-like HIV particles” or as HIV. Our sequencing results showed a very high homology (over 90%) between bacterial HIV-like sequences and HIV-1 isolate HXB2 (HIVHXB2CG). Because all the above mentioned species are gut or skin commensals that cannot be eliminated, they may represent continual imminency for the host.
On the other hand, differences in homology of patient’s
There is increasing evidence that the mucosa-associated bacteria may play important roles in the pathogenesis of inflammatory bowel disease, ulcerative colitis, Crohn’s disease and potentially even colon cancer [14,15]. Invasive strains of
Conclusions
Bacteria and yeasts from the respiratory tract of 41% of Cambodian and 31% of Kenyan HIV-positive children bear HIV-like sequences. According to our preliminary results, we conclude that the ability of invasive bacteria containing HIV sequences in the form of “virus-like particles” to enter into HL-60 cells or human lymphocytes represents an ideal system for of horizontal transfer of genes between eukaryotic and prokaryotic cells. In this way “virus-like particles” or other particles are introduced into cells of the lymphoproliferative system, and, consequently, their genetic information may interact with or be integrated into the human DNA and induce the HIV disease process [7,8].
References
1. Mattapallil JJ, Daniel C, Douek DC, Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection: Nature, 2005; 434; 1093-97, pmid: 15793563
2. Li QS, Duan LJ, Estes JD, Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells: Nature, 2005; 434; 1148-52, pmid: 15793562
3. Guadalupe M, Sankaran S, George MD, Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type1-infected patients initiating therapy during primary or chronic infection: J Virol, 2006; 80; 8236-47, pmid: 16873279
4. Chun TW, Davey RT, Ostrowski M, Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy: Nature Med, 2000; 6; 757-61, pmid: 10888923
5. Siliciano JD, Kajdas J, Finzi D, Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells: Nature Med, 2003; 9; 727-28, pmid: 12754504
6. Nelson JA, Wiley CA, Reynolds-Kohler C, HIV detected in bowel epithelium from patients with gastrointestinal symptoms: Lancet, 1988; 6; 259-62, pmid: 2893081
7. Zajac V, Kovac M, Ciernikova S, Detection of HIV sequences in colon bacteria of AIDS positive patients: Clin Microbiol Infec Suppl, 2005; 11; 53
8. Zajac V, Mego M, Martinicky D, Testing of bacteria isolated from HIV/AIDS patients in experimental models: Neuroendocrinology Letters, 2006; 27; 101-4
9. Zajac V, Stevurkova V, Matelova L, Ujhazy E, Detection of HIV-1 sequences in intestinal bacteria of HIV/AIDS patients: Neuroendocrinology Letters, 2007; 28; 591-95, pmid: 17984947
10. Wilson KH, Blitchington RB, Greene RC, Amplification of bacterial 16S Ribosomal DNA with polymerase chain reaction: J Clin Microbiol, 1990; 28; 1942-46, pmid: 2095137
11. Maniatis T, Frisch EF, Sambrook J: Molecular cloning a laboratory manual, 1982, Cold Spring Harbor Laboratory
12. Zajac V, Kirchhoff T, Levy ER, Characterisation of an X;17(q12;p13) translocation breakpoint in a female patient with hypomelanosis of Ito and choroid plexus papilloma: Eur J Hum Genet, 1997; 5; 61-68, pmid: 9195154
13. Veazey RS, Lackner AA, HIV swiftly guts the immune system: Nature Med, 2005; 11; 469-70, pmid: 15875046
14. Martin MH, Campbell BJ, Hart CA, Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer: Gastroenterology, 2004; 127; 80-93, pmid: 15236175
15. Darfeuille-Michaud A, Boudeau J, Bulois P, High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease: Gastroenterology, 2004; 127; 412-21, pmid: 15300573
16. Heinemann JA, Sprague Gf, Bacterial conjugative plasmids mobilize DNA transfer between bacteria and yeast: Nature, 1989; 340; 205-9, pmid: 2666856
17. Zambryski PC, Chronicles from Agrobacterium – plant cell DNA transfer story: Annu Rev Plant Physiol Plant Mol Biol, 1992; 43; 465-90
18. Walters VL, Conjugation between bacterial and mammalian cells: Nature Genetics, 2001; 29; 375-76, pmid: 11726922
19. Grillot-Courvalin C, Goussard S, Huetz F, Functional gene transfer from intracellular bacteria to mammalian cells: Nature Biotechnology, 1998; 16; 862-66
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






